Issue 7, 2023

Lipid-based colloidal nanoparticles for applications in targeted vaccine delivery

Abstract

Bioactive molecules and their effects have been influenced by their solubility and administration route. In many therapeutic reagents, the performance of therapeutics is dependent on physiological barriers in the human body and delivery efficacy. Therefore, an effective and stable therapeutic delivery promotes pharmaceutical advancement and suitable biological usage of drugs. In the biological and pharmacological industries, lipid nanoparticles (LNPs) have emerged as a potential carrier to deliver therapeutics. Since studies reported doxorubicin-loaded liposomes (Doxil®), LNPs have been applied to numerous clinical trials. Lipid-based nanoparticles, including liposomes, solid lipid nanoparticles (SLNs), and nanostructured lipid nanoparticles, have also been developed to deliver active ingredients in vaccines. In this review, we present the type of LNPs used to develop vaccines with attractive advantages. We then discuss messenger RNA (mRNA) delivery for the clinical application of mRNA therapeutic-loaded LNPs and recent research trend of LNP-based vaccine development.

Graphical abstract: Lipid-based colloidal nanoparticles for applications in targeted vaccine delivery

Article information

Article type
Review Article
Submitted
10 Nov. 2022
Accepted
15 Feb. 2023
First published
17 Feb. 2023
This article is Open Access
Creative Commons BY-NC license

Nanoscale Adv., 2023,5, 1853-1869

Lipid-based colloidal nanoparticles for applications in targeted vaccine delivery

M. S. Khan, S. A. Baskoy, C. Yang, J. Hong, J. Chae, H. Ha, S. Lee, M. Tanaka, Y. Choi and J. Choi, Nanoscale Adv., 2023, 5, 1853 DOI: 10.1039/D2NA00795A

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements